FOLH1 and prostate cancer: Magnetic resonance imaging (MRI) is one of the common imaging modalities to diagnose prostate cancer, and recently several studies compared the diagnostic performance of multi-parametric MRI (mpMRI) with 68 Ga-PSMA PET/CT.